Holderness Investments Company’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.49M | Sell |
10,720
-18
| -0.2% | -$2.52K | 0.3% | 80 |
|
|
2025
Q4 | $1.32M | Sell |
10,738
-50
| -0.5% | -$6.08K | 0.27% | 76 |
|
|
2025
Q3 | $1.2M | Buy |
10,788
+130
| +1% | +$14.8K | 0.24% | 79 |
|
|
2025
Q2 | $1.18M | Buy |
10,658
+151
| +1% | +$16.1K | 0.25% | 80 |
|
|
2025
Q1 | $1.18M | Hold |
10,507
| – | – | 0.27% | 81 |
|
|
2024
Q4 | $971K | Sell |
10,507
-339
| -3% | -$30.5K | 0.21% | 103 |
|
|
2024
Q3 | $909K | Sell |
10,846
-128
| -1% | -$9.77K | 0.2% | 110 |
|
|
2024
Q2 | $753K | Sell |
10,974
-364
| -3% | -$24.3K | 0.18% | 117 |
|
|
2024
Q1 | $831K | Sell |
11,338
-32
| -0.3% | -$2.46K | 0.2% | 117 |
|
|
2023
Q4 | $921K | Sell |
11,370
-125
| -1% | -$9.73K | 0.25% | 93 |
|
|
2023
Q3 | $861K | Buy |
11,495
+3
| +0% | +$231 | 0.34% | 77 |
|
|
2023
Q2 | $886K | Buy |
11,492
+190
| +2% | +$15.2K | 0.33% | 74 |
|
|
2023
Q1 | $938K | Buy |
11,302
+178
| +2% | +$14.7K | 0.37% | 69 |
|
|
2022
Q4 | $955K | Buy |
11,124
+56
| +0.5% | +$4.43K | 0.41% | 66 |
|
|
2022
Q3 | $683K | Buy |
11,068
+574
| +5% | +$36.2K | 0.31% | 83 |
|
|
2022
Q2 | $649K | Sell |
10,494
-766
| -7% | -$47.4K | 0.27% | 93 |
|
|
2022
Q1 | $669K | Buy |
11,260
+623
| +6% | +$39.8K | 0.22% | 104 |
|
|
2021
Q4 | $772K | Buy |
10,637
+736
| +7% | +$50.7K | 0.23% | 107 |
|
|
2021
Q3 | $692K | Buy |
9,901
+137
| +1% | +$9.63K | 0.23% | 110 |
|
|
2021
Q2 | $672K | Buy |
9,764
+678
| +7% | +$45.3K | 0.22% | 109 |
|
|
2021
Q1 | $587K | Sell |
9,086
-289
| -3% | -$18.6K | 0.21% | 112 |
|
|
2020
Q4 | $546K | Buy |
9,375
+2,798
| +43% | +$169K | 0.21% | 109 |
|
|
2020
Q3 | $416K | Buy |
6,577
+278
| +4% | +$19.3K | 0.17% | 119 |
|
|
2020
Q2 | $485K | Buy |
6,299
+2,619
| +71% | +$201K | 0.22% | 108 |
|
|
2020
Q1 | $275K | Buy |
+3,680
| New | +$254K | 0.16% | 129 |
|
|
2019
Q3 | – | Sell |
-3,257
| Closed | -$220K | – | 186 |
|
|
2019
Q2 | $220K | Sell |
3,257
-140
| -4% | -$9.21K | 0.1% | 179 |
|
|
2019
Q1 | $221K | Sell |
3,397
-31
| -0.9% | -$2.06K | 0.11% | 172 |
|
|
2018
Q4 | $214K | Sell |
3,428
-654
| -16% | -$45.7K | 0.12% | 161 |
|
|
2018
Q3 | $315K | Sell |
4,082
-350
| -8% | -$26.4K | 0.14% | 156 |
|
|
2018
Q2 | $314K | Sell |
4,432
-100
| -2% | -$7.06K | 0.15% | 146 |
|
|
2018
Q1 | $342K | Buy |
4,532
+631
| +16% | +$50.2K | 0.17% | 141 |
|
|
2017
Q4 | $279K | Sell |
3,901
-31
| -0.8% | -$2.35K | 0.14% | 158 |
|
|
2017
Q3 | $319K | Sell |
3,932
-500
| -11% | -$38.2K | 0.17% | 146 |
|
|
2017
Q2 | $314K | Buy |
4,432
+426
| +11% | +$28.3K | 0.17% | 146 |
|
|
2017
Q1 | $272K | Buy |
+4,006
| New | +$282K | 0.14% | 163 |
|
Other funds holding GILD
VCM
VPM
Holderness Investments Company's GILD Position: Q1 2026 in Review
Holderness Investments Company reduced its Gilead Sciences (GILD) stake by 0.17% in Q1 2026, selling an estimated $2.52K and leaving 10,720 shares worth $1.49M. The position accounts for 0.3% of the portfolio, ranked #80.
Holderness Investments Company first reported a position in GILD in Q1 2017 and has held it in 35 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Holderness Investments Company held 10,720 shares of Gilead Sciences worth $1.49M as of Q1 2026.
- Holderness Investments Company sold 18 Gilead Sciences shares in Q1 2026, an estimated $2.52K.
- Gilead Sciences made up 0.3% of Holderness Investments Company's portfolio in Q1 2026, its #80 holding.
- Holderness Investments Company first reported a position in Gilead Sciences in Q1 2017 and has held it in 35 quarters since.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Holderness Investments Company's 13F filing for Q1 2026, filed 12 May 2026.